Using of Bromocriptine Therapy with Clomiphene Citrate in Comparison with the Use of Clomiphene Alone in Polysystic Ovary Disease (PCOD)

Abstract

This study was a prospective study which was done in Tikrit Teaching Hospital to compare the use of Bromocriptine with Clomiphine Citrate and Chlomiphine alone in Normoprolactinemic anovulatory women with (PCOD). A total of 44 infertile Normoprolactinemic women, these women were divided into two group, each group of (22) women, the first group was treated with Bromocriptine (2.5) mg twice per day and with Clomiphine Citrate (100) mg per day from second to six day of cycle for three month duration, second group was treated with Clomiphine Citrate also the same dose as mentioned above. After treatment regular mences resumed in 68.2 % for the first group and 50 % for the second group, the pregnancy rate were 40% for the first group and 22.7 % for the second group. The final conclusions in this study were that Clomiphine Citrate with Bromocriptine showed higher rate of regular resumption on mences and pregnancy than Clomiphine alone.